DEPO Overview
Upcoming Projects (DEPO)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (DEPO)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (DEPO)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (DEPO)
-
Depomed Prevails in NUCYNTA Franchise ANDA Litigation Providing Market Exclusivity Until December 2025
Ticker: DEPO
Occurred on: Sep 30, 2016 -
Data from two posters describe studies of NUCYNTA ER conducted by the Rocky Mountain Poison & Drug Center analyzing data
Ticker: DEPO
Occurred on: Sep 08, 2016 -
Depomed Releases Lazanda 300 mcg Dose for Treatment of Breakthrough Cancer Pain
Ticker: DEPO
Occurred on: Jul 07, 2016 -
Cebranopadol Phase IIb Data Presented at World Institute of Pain Congress
Ticker: DEPO
Occurred on: May 23, 2016 -
Depomed Announces Closing of Acquisition of U.S. Rights to Cebranopadol From Grunenthal
Ticker: DEPO
Occurred on: Jan 04, 2016
Strategic Initiatives (DEPO)
